Try our beta test site
Trial record 1 of 2 for:    vs5584
Previous Study | Return to List | Next Study

Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

This study has been terminated.
(Lack of recruitment and the company's decision to de-prioritize 5584 development)
Sponsor:
Information provided by (Responsible Party):
Verastem, Inc.
ClinicalTrials.gov Identifier:
NCT01991938
First received: November 18, 2013
Last updated: January 26, 2017
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2016
  Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)